Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
3.849
+0.049 (1.28%)
Jan 17, 2025, 4:00 PM EST - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $20.92 million as of January 17, 2025. Its market cap has increased by 7.24% in one year.
Market Cap
20.92M
Enterprise Value
-5.33M
1-Year Change
7.24%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has increased from $18.94M to $20.92M, an increase of 10.47%. That is a compound annual growth rate of 3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 20.92M | 16.98% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |